Skip to main content
رجوع
YDES logo

YD Bio Limited Ordinary Shares

جودة البيانات: 100%
YDES
NASDAQ Healthcare Biotechnology
KWD 7.73
▲ KWD 1.24 (19.11%)
القيمة السوقية: 545.13M
نطاق اليوم
KWD 6.58 KWD 8.77
نطاق 52 أسبوعًا
KWD 5.30 KWD 25.00
حجم التداول
138,671
متوسط 50 يوم / 200 يوم
KWD 9.76 / KWD 12.68
الإغلاق السابق
KWD 6.49

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -386.2 0.4
P/B 82.7 2.9
ROE % -42.7 3.9
Net Margin % -276.6 3.8
Rev Growth 5Y % 10.0
D/E 0.0 0.2

النقاط الرئيسية

Earnings declined -10509.73% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -4.75M
PEG of 0.00 suggests growth is underpriced
Capital intensive — 570.38% of revenue goes to capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)45.76%
Earnings (1Y)-10509.73%
FCF Growth (3Y)N/A

الجودة

Return on Equity
-42.69%
ROIC-16.58%
Net Margin-276.58%
Op. Margin-286.45%

الأمان

Debt / Equity
0.00
Current Ratio13.18
Interest Coverage-1893.69

التقييم

P/E Ratio
-386.19
P/B Ratio82.72
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 45.76% Revenue Growth (3Y) N/A
Earnings Growth (1Y) -10509.73% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 510,360.0 Net Income (TTM) -1.41M
ROE -42.69% ROA -20.56%
Gross Margin 30.44% Operating Margin -286.45%
Net Margin -276.58% Free Cash Flow (TTM) -4.75M
ROIC -16.58% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 13.18
Interest Coverage -1893.69 Dividend Yield 0.00%
Valuation
P/E Ratio -386.19 P/B Ratio 82.72
P/S Ratio 1068.13 PEG Ratio 0.00
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 545.13M Enterprise Value 542.02M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 510,360.0 350,131.0 0.0 0.0 0.0
Net Income -1.41M 13,560.0 3.79M 8.70M -2.54M
EPS (Diluted) -0.56 0.00 0.41 0.59 -0.17
Gross Profit 155,356.0 153,445.0 0.0 0.0 0.0
Operating Income -1.46M -9,847.0 -2.32M -1.72M -344,223.0

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 6.86M 321,212.0 17.93M 118.06M 117.59M
Total Liabilities 273,980.0 298,218.0 6.74M 9.11M 17.81M
Shareholders' Equity 6.59M 22,994.0 11.20M 108.96M 99.78M
Total Debt 22,555.0 47,576.0 0.0 0.0 0.0
Cash & Equivalents 3.13M 87,098.0 14,129.0 5,403.0 693,818.0
Current Assets 3.47M 271,724.0 202,705.0 129,560.0 830,767.0
Current Liabilities 263,060.0 298,218.0 5.55M 2.00M 302,219.0